(CercleFinance.com) – Groupe Bruxelles Lambert (GBL) announces that it has entered into definitive agreements for the acquisition of the majority of the capital of Affidea, the European leader in medical diagnostic services, from B-Flexion. The transaction is expected to close in the third quarter of 2022.
The Belgian investment company will invest up to one billion euros of equity in this transaction. “This investment in a defensive sector offers GBL both resilience and diversification of its portfolio,” she explains.
A leading European player in medical imaging services with 320 centers in 15 countries, Affidea has an offer covering the entire value chain, from advanced medical imaging services to outpatient care and cancer treatment.
Copyright © 2022 CercleFinance.com. All rights reserved.
Did you like this article ? Share it with your friends with the buttons below.
